Cytokinetics Inc. buy UBS Group AG
Start price
03.04.23
/
50%
€34.60
Target price
03.04.24
€56.02
Performance (%)
87.86%
End price
04.04.24
€65.00
Summary
This prediction ended on 04.04.24 with a price of €65.00. The BUY prediction by UBS_Group_AG for Cytokinetics Inc. saw massive gains of 87.86%. UBS_Group_AG has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytokinetics Inc. | -0.778% | -0.778% | 125.714% | 119.735% |
| iShares Core DAX® | 2,57 % | 5,33 % | 8,27 % | 63,86 % |
| iShares Nasdaq 100 | 4,86 % | 0,45 % | 27,08 % | 86,27 % |
| iShares Nikkei 225® | 5,59 % | -0,59 % | 48,55 % | 78,35 % |
| iShares S&P 500 | 3,25 % | 2,50 % | 23,35 % | 68,71 % |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at UBS Group AG from $67.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten